ICICI Prudential Pharma Healthcare and DiagnosticsFund
Direct · Growth ₹47.54
04 Aug 2026
NAV
24.3%
3Y CAGR
24.2%
5Y CAGR
23.9%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
3.32
Sharpe
-20.6%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.85 L | 26.3% | -23.4% | 108.1% |
| 3 Years | ₹36.00 L | ₹51.47 L | 24.8% | 2.5% | 44.5% |
| 5 Years | ₹60.00 L | ₹1.06 Cr | 24.4% | 16.0% | 33.6% |
| 7 Years | ₹84.00 L | ₹1.90 Cr | 23.4% | 19.4% | 26.9% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 26.3% | 14.5% | 13.9% | +11.8% |
| 3 Years | 24.8% | 11.2% | 16.8% | +13.6% |
| 5 Years | 24.4% | 10.4% | 16.9% | +13.9% |
| 7 Years | 23.4% | 10.6% | 16.6% | +12.8% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 25.6% | 20.1% | -12.3% | 94.3% | 0.74 | 3.35 | 81% | — | — |
| 3 Years | 24.3% | 25.3% | 14.7% | 31.6% | 4.10 | — | 100% | — | — |
| 5 Years | 24.2% | 24.8% | 16.0% | 34.8% | 3.32 | — | 100% | — | — |
-20.6%
Max Drawdown
1 mo
Drawdown Duration
1 mo
Recovery Time
-5.2%
Avg Drawdown
Calmar Ratio by Duration
1.25
1Y
1.18
3Y
1.18
5Y
1.12
7Y
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +7.90 | 0.67 | 74.6% | 61.2% | 10.2% | 0.2% |
| 3 Years | +16.28 | 0.63 | 79.3% | 56.1% | 24.1% | 8.5% |
| 5 Years | +8.70 | 0.58 | 65.6% | 52.1% | 16.6% | 9.0% |
| 7 Years | +16.05 | 0.53 | 62.8% | 44.3% | 25.7% | 12.5% |
| 10 Years | +9.46 | 0.53 | 61.1% | 45.0% | 17.0% | 8.4% |
| 12 Years | +7.22 | 0.53 | 61.1% | 45.0% | 14.0% | 7.0% |
| 15 Years | +5.03 | 0.53 | 61.1% | 45.0% | 11.0% | 5.6% |
33
Total Holdings
60.7%
Top 10 Weight
5
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 12.09% |
| 2 | Dr. Reddy's Laboratories Ltd. | 7.70% |
| 3 | Cipla Ltd. | 7.45% |
| 4 | Mankind Pharma Ltd. | 7.03% |
| 5 | Divi's Laboratories Ltd. | 6.06% |
| 6 | Biocon Ltd. | 4.71% |
| 7 | Cohance Lifesciences Ltd. | 4.37% |
| 8 | Alkem Laboratories Ltd. | 4.08% |
| 9 | Medplus Health Services Ltd | 3.86% |
| 10 | MAX Healthcare Institute Ltd | 3.36% |